Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for[...]
Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for[...]
03/11/2024 | Press release | Distributed by Public on 03/11/2024 16:50
Please select the service you want to use:
Smartlinks | Fras-le SA | Company News | Manufacturing | Automotive | Securities Issuers | Motor Vehicles Parts and Accessories Manufacturers | Sao Paulo Stock Exchange (B3)
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact